HERCULES, Calif. – Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced the launch of the Reliance Select cDNA Synthesis Kit to help researchers efficiently convert RNA to DNA by reverse transcription. Converting RNA to DNA is the crucial first step in the study of […]
25 Trials Utilizing Mass Cytometry Initiated in 2020 SOUTH SAN FRANCISCO, Calif. — Fluidigm Corporation (NASDAQ:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today announced that its mass cytometry technologies, including CyTOF® , Imaging Mass Cytometry (IMC), and Maxpar® Direct™, have been used in 113 National Clinical Trials listed […]
Launch of two NGS panels enables comprehensive detection of genetic abnormalities involved in breast and ovarian cancer, and myeloid disorders Oxford, UK – Oxford Gene Technology (OGT), a Sysmex Group Company, has today announced the expansion of its SureSeq™ range of next generation sequencing (NGS) panels to facilitate the interrogation of genes involved in breast and ovarian cancer, […]
Addition of CRISPR and RNAi offerings to complement PerkinElmer’s life sciences and applied genomics solutions, with future opportunities to improve cell based discovery for precision medicine WALTHAM, Mass. — PerkinElmer, Inc. (NYSE: PKI) (“PerkinElmer”) and Horizon Discovery Group plc (LSE: HZD) (“Horizon”) are pleased to announce that they have reached an agreement on the terms of a recommended […]
The StarBright Blue 700, StarBright Violet 440 and StarBright Violet 610 Dyes offer maximal brightness for improved resolution HERCULES, Calif. – Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today launched three StarBright Dyes specifically developed for flow cytometry. StarBright Blue 700, StarBright Violet 440, […]
SANTA CLARA, Calif. — Agilent Technologies Inc. (NYSE: A) has announced the signing of a memorandum of understanding (MOU) with GI Innovation (GII), a Korean clinical-stage biopharmaceutical company. The MOU establishes a framework in which the two companies will enter into a strategic partnership to explore potential genomic biomarkers of the tumor microenvironment in an early-phase […]
Illkirch, FRANCE – Polyplus-transfection® SA (“Polyplus”), the leading biotechnology company that supports the gene and cell therapy market by supplying innovative transfection solutions, today named Mario Philips as Chief Executive Officer (“CEO”). Mr. Philips succeeds Karsten Wilking, who will transition into a Strategic Advisor role. In addition, Polyplus has named Dr. Andreas Rummelt and Jean-Paul […]
Amsterdam, the Netherlands — 30 October 2020 — LUMICKS is pleased to announce a collaboration agreement with clinical-stage biotech company Leucid Bio, which seeks to utilize LUMICKS’ z-Movi® Cell Avidity Analyzer (z-Movi) to accelerate entry of immunotherapeutic candidates into clinical trials. The goal of the partnership is to evaluate the efficacy of Leucid Bio’s next-generation chimeric antigen receptor (CAR) T-cells using the […]
Company elects luminary as Chairman as they reimagine where Mass Spec technology can be used when it is small in size, low in cost, and simple to operate BOSTON — 908 Devices, a pioneer of purpose-built handheld and desktop Mass Spec devices for chemical and biomolecular analysis, today announced the appointment of Kevin Hrusovsky as the Chairman of […]
By combining two assays in a single platform, the integrated solution offers deeper insight into therapy resistance and relapse, saving billions in drug development costs SOUTH SAN FRANCISCO, Calif. — Mission Bio, Inc. today announced the launch of a complete Tapestri® Single-cell Multi-omics Solution, the most comprehensive single-cell multi-omics platform on the market. With a new […]
Pay Invoice
Latest Blogs
-
Automation Provides a Boost for Sample Prep Instrument Market Growth
August 25, 2026 11:49 am
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
